Abstract:BACKGROUND:Neoadjuvant chemotherapy (NAC) is an effective therapeutic regimen for patients with breast cancer. However, some individuals cannot benefit from NAC because of drug resistance. To date, valid strategies about enhancing sensitivity of breast cancer to NAC are still scarce. miRNAs have been reported to proverbially be involved in the onset and development of malignancies including drug resistance.METHODS:GSE73736 was downloaded from the GEO database. Student's t-test was conducted to acquire differentially expressed-miRNAs (DE-miRNAs). Potential target genes of DE-miRNAs were predicted by miRTarBase. Gene Ontology annotation and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses for these target genes were performed by database for annotation, visualization, and integrated discovery. Protein-protein interaction network was constructed by STRING database and visualized through Cytoscape software. The hub target gene-miRNA network was also established by Cytoscape software. Next, the expression of potential functional miRNAs in breast cancer cell lines and tissues was determined. Finally, the roles of miR-3617-3p, miR-3136-3p, and miR-520b in modulating breast cancer chemoresistance were further examined.RESULTS:A total of 123 DE-miRNAs were identified, including 60 upregulated miRNAs and 63 downregulated miRNAs in the chemoresistant breast cancer group when compared with the chemosensitive group. Six hundred and seventeen and 1,146 potential target genes for the top 10 most upregulated and downregulated miRNAs were predicted, respectively. Enrichment analyses revealed that these target genes were enriched in some cancer-associated or chemo-resistance-associated pathways, such as MAPK signaling pathway, wnt signaling pathway, and p53 signaling pathway. MAPK1 and PRDM10 were identified as hub genes in the protein-protein interaction network. The top 25 hub genes were potentially regulated by 16 DE-miRNAs, among which miR-3617-3p and miR-3136-3p were commonly upregulated, whereas miR-520b was downregulated in two chemoresistant breast cancer cells compared with chemosensitive cell. By analyzing TCGA data, we found that expression of miR-3136-3p and miR-520b was increased and decreased in breast cancer tissues, respectively. Moreover, functional experiments demonstrated that miR-3136-3p and miR-3617-3p could reduce chemosensitivity of breast cancer, whereas miR-520b could reverse chemoresistance.CONCLUSION:The present study, based on bioinformatics analysis and experimental validation, brings to light novel mechanisms of breast cancer NAC resistance.

Genome-Wide Analysis Of Mirna Signature Differentially Expressed In Doxorubicin-Resistant And Parental Human Hepatocellular Carcinoma Cell Lines

MicroRNA-383 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma by Targeting Eukaryotic Translation Initiation Factor 5A2.

Global Analysis of miRNA Signature Differentially Expressed in Insulin-resistant Human Hepatocellular Carcinoma Cell Line

MiR-34a Overexpression Enhances the Inhibitory Effect of Doxorubicin on HepG2 Cells

The effect of miR-199a on drug resistance of hepatocellular carcinoma cells by regulating MDR1/P-gp expression

Microrna Expression Prohles in Acquired Gehtinib-Resistant Human Lung Adenocarcinoma Cell Line PC9/AB2 Vs Its Parental Cell Line PC9

Mir-340 Reverses Cisplatin Resistance Of Hepatocellular Carcinoma Cell Lines By Targeting Nrf2-Dependent Antioxidant Pathway

European Survey of Primary Care Physician Perceptions on Heart Failure Diagnosis and Management (Euro-Hf).

Identification of Chemoresistance-Associated Mirnas in Breast Cancer

miRNAs as short non-coding RNAs in regulating doxorubicin resistance

Downregulation of Mir-33A-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.

Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells

Mir-26B Enhances the Sensitivity of Hepatocellular Carcinoma to Doxorubicin Via USP9X-dependent Degradation of P53 and Regulation of Autophagy

Identification of Microrna Profiles in Docetaxel-Resistant Human Non-Small Cell Lung Carcinoma Cells (SPC-A1)

Screening and Identification of Microrna Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer

Doxorubicin resistance in breast cancer xenografts and cell lines can be counterweighted by microRNA-140-3p, through PD-L1 suppression

Identification of Mirna Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response

MicroRNA Expression Profiling Involved in Doxorubicin-Induced Cardiotoxicity Using High-Throughput Deep-Sequencing Analysis

Microrna-760 Inhibits Doxorubicin Resistance In Hepatocellular Carcinoma Through Regulating Notch1/Hes1-Pten/Akt Signaling Pathway

MicroRNA-215 is Upregulated by Treatment with Adriamycin and Leads to the Chemoresistance of Hepatocellular Carcinoma Cells and Tissues.

Upregulated Mir-182 Increases Drug Resistance in Cisplatin-Treated HCC Cell by Regulating TP53INP1.